Tower Research Capital (TRC)’s NRX Pharmaceuticals, Inc. Warrant NRXPW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15
| Closed | -$2 | – | 5608 |
|
|
2024
Q4 | $2 | Hold |
15
| – | – | ﹤0.01% | 5652 |
|
|
2024
Q3 | $1 | Hold |
15
| – | – | ﹤0.01% | 5677 |
|
|
2024
Q2 | $1 | Hold |
15
| – | – | ﹤0.01% | 5649 |
|
|
2024
Q1 | $3 | Hold |
15
| – | – | ﹤0.01% | 5805 |
|
|
2023
Q4 | $2 | Hold |
15
| – | – | ﹤0.01% | 5882 |
|
|
2023
Q3 | $1 | Hold |
15
| – | – | ﹤0.01% | 5915 |
|
|
2023
Q2 | $4 | Hold |
15
| – | – | ﹤0.01% | 5955 |
|
|
2023
Q1 | $0 | Hold |
15
| – | – | ﹤0.01% | 6135 |
|
|
2022
Q4 | $0 | Hold |
15
| – | – | ﹤0.01% | 6213 |
|
|
2022
Q3 | $0 | Hold |
15
| – | – | ﹤0.01% | 6348 |
|
|
2022
Q2 | $0 | Hold |
15
| – | – | ﹤0.01% | 6386 |
|
|
2022
Q1 | $0 | Hold |
15
| – | – | ﹤0.01% | 6418 |
|
|
2021
Q4 | $0 | Hold |
15
| – | – | ﹤0.01% | 6424 |
|
|
2021
Q3 | $0 | Hold |
15
| – | – | ﹤0.01% | 6039 |
|
|
2021
Q2 | $0 | Buy |
+15
| New | – | ﹤0.01% | 5722 |
|